Loading...
Dernières publications
-
Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
-
Corinna Preuße, Barbara Paesler, Christopher Nelke, Derya Cengiz, Thomas Müntefering, et al.. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathologica, 2022, 144 (2), pp.353-372. ⟨10.1007/s00401-022-02438-z⟩. ⟨hal-03830925⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-03832478⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-04002766⟩
-
Stéphane Ederhy, Perrine Devos, Bruno Pinna, Elisa Funck-Brentano, Baptiste Abbar, et al.. 8 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography imaging for the diagnosis of immune checkpoint inhibitors associated myocarditis. Archives of cardiovascular diseases, 2022, ⟨10.1016/j.acvd.2021.12.001⟩. ⟨hal-03561783⟩
-
Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas de Prost, et al.. Plasma exchange are not associated with better outcome in MDA5 rapidly-progressive interstitial lung disease. French Intensive Care Society International Congress 2022, 2022, paris, France. pp.54, ⟨10.1186/s13613-022-01016-6⟩. ⟨hal-03831253⟩
-
Franck Phan, Samia Boussouar, Olivier Lucidarme, Mohamed Zarai, Joe-Elie Salem, et al.. Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients. Cardiovascular Diabetology, 2021, 20, pp.165. ⟨10.1186/s12933-021-01327-1⟩. ⟨hal-03346419⟩
Chiffres clés
121
Publications avec texte intégral
Open Access
53 %
Mots clés
Biopsy
Cytokines
Acute Kidney Injury/epidemiology/etiology
Amyotrophic lateral sclerosis
Antisynthetase
Auto-immunité
Data integration
Arthritis
Outcome measures
AAV vector
Anti-drug antibodies
Gene therapy
Anti-interleukin-6
Case reports
Inborn errors of metabolism
Anti-synthetase syndrome
Auto‐antibodies
Anticorps spécifique des myosites
Antibody responses
Active
DM
Anti-Mi2
Machine learning
Muscle
Anémie hémolytique
Mass cytometry
Autoantibody
Idiopathic inflammatory myopathies
Polymyositis
Auto-antibodies
Dependovirus/genetics/immunology
AAV antibody
Abnormal movement
Biomarkers
Fabry disease
IBM
Myocarditis
Antiphospholipid syndrome
Aldosterone
AAV
Antibodies
Myopathy
Autoimmune diseases
Immunotherapy
Myositis and muscle disease
Systems biology
CD8+T cells
Biomarker
Adeno-associated vector
Female
Anti‐mitochondrial antibodies
CD8+ T-bet+ cells
Antisynthetase syndrome
Adeno-associated virus
Cancer
Sphingosine-1-phosphate
Adolescence
Adjudication
Lysosomal storage diseases
Dermatomyositis
Multidisciplinarity
Inflammation
Middle Aged
Biomarqueurs
AAV humoral immunity
Inflammatory myopathy
Humans
Anti-IgE IgG
Myositis
Autoimmunity
AAV vectors
Anti-MDA5 autoantibodies
Adeno-associated virus vector
B cell homeostasis
Male
Adverse drug reactions
Acid-alpha-glucosidase
Assisted communication devices
Agalsidase
Aged
Antisynthétase
Analyses multidimensionnelles
Amyotrophy
Interstitial lung disease
COVID-19
Anticorps anti-agalsidase
Immune checkpoint inhibitors
Bioelectrical impedance analysis
B-lymphocyte
Prognosis
Aldostérone
Animals
Inclusion body myositis
Skeletal muscle
Adult
Deep immune profiling
IMNM
Interferon
Autoantibodies
Anti-agalsidase antibodies